0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Whole Exome Sequencing Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
Published Date: June 2025
|
Report Code: QYRE-Auto-5105
Home | Market Reports | Science| Biological Sciences
Global Whole Exome Sequencing Market Size Status and Forecast 2021 2027
BUY CHAPTERS

Global Whole Exome Sequencing Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031

Code: QYRE-Auto-5105
Report
June 2025
Pages:118
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Whole Exome Sequencing Market Size

In 2024, the global market size of Whole Exome Sequencing was estimated to be worth US$ 367 million and is forecast to reach approximately US$ 773 million by 2031 with a CAGR of 11.4% during the forecast period 2025-2031.

Whole Exome Sequencing Market

Whole Exome Sequencing Market

Exome sequencing is a capture based method developed to identify variants in the coding region of genes which affect protein function. While exome capture methods using PCR, hybrid capture and molecular inversion probes exist, the most common and efficient strategies are in-solution capture methods. In-solution capture utilizes pools of oligonucleotides or probes bound to magnetic beads, whose sequence has been designed to hybridize to exon regions. After binding to genomic DNA, these probes are pulled down and washed, allowing exon regions to be selectively sequenced.
While there are approximately 180,000 exons in the human genome, constituting less than 2% of total sequence, the exome contains ~80-90% of known disease causing variants making it a cost-effective alternative to whole genome sequencing. When performing exome-seq, users should not only consider average on-target coverage but also the local coverage of particular sites of interest. When choosing between exome and whole genome sequencing (WGS), consider that exome sequencing has the advantage that oligonucleotides are designed to particular genomic regions where typical coverage with WGS is not enough for SNP calling. It is also more affordable enabling the analysis of more individuals and populations. With WGS, you can detect variants in regions not covered by exome capture allowing or the identification of structural and non-coding variants associated with disease.
The major players in global Whole Exome Sequencing market include Illumina, Thermofisher, Roche, etc. The top 3 players occupy about 45% shares of the global market. North America and Europe are main markets, they occupy about 70% of the global market. Illumina TruSeq Exome and Roche Nimblegen SeqCap are main types, with a share about 55%. Mendelian Disease and Rare Syndrome Gene Discovery are the main application, which hold a share about 40%.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Whole Exome Sequencing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Whole Exome Sequencing.
The Whole Exome Sequencing market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Whole Exome Sequencing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Whole Exome Sequencing companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Market Segmentation

Scope of Whole Exome Sequencing Market Report

Report Metric Details
Report Name Whole Exome Sequencing Market
Forecasted market size in 2031 approximately US$ 773 million
CAGR 11.4%
Forecasted years 2025 - 2031
Segment by Type
  • Agilent HaloPlex
  • Agilent SureSelect
  • Agilent SureSelect QXT
  • Illumina TruSeq Exome
  • Roche Nimblegen SeqCap
  • MYcroarray MYbaits
Segment by Application
  • Correlation Research of Normal Human
  • Mendelian Disease and Rare Syndrome Gene Discovery
  • The Research of Complex Diseases
  • Mouse Exome Sequencing
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Illumina, Thermo Fisher, Roche, Angilent, Eurofins, Sengenics, Ambry, Macrogen, BGI, Novo Gene
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on.
  • Chapter 2: Revenue of Whole Exome Sequencing in global and regional level.
  • Chapter 3: Detailed analysis of Whole Exome Sequencing company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Whole Exome Sequencing revenue, gross margin, and recent development, etc.
  • Chapter 5: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 6: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 7: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
  • Chapter 8: Europe by Type, by Application and by country, revenue for each segment.
  • Chapter 9: Asia Pacific by Type, by Application and by region, revenue for each segment.
  • Chapter 10: Latin America by Type, by Application and by country, revenue for each segment.
  • Chapter 11: Middle East and Africa, by Type, by Application and by country, revenue for each segment.
  • Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
  • Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 14: Research Findings and Conclusion

FAQ for this report

What is the Whole Exome Sequencing Market size in 2031?

Ans: The Whole Exome Sequencing Market size in 2031 will be approximately US$ 773 million.

What is the market share of major companies in Whole Exome Sequencing Market?

Ans: The top 3 players occupy about 45% shares of the global market.

What is the Whole Exome Sequencing Market share by application?

Ans: Mendelian Disease and Rare Syndrome Gene Discovery are the main application, which hold a share about 40%.

Who are the main players in the Whole Exome Sequencing Market report?

Ans: The main players in the Whole Exome Sequencing Market are Illumina, Thermo Fisher, Roche, Angilent, Eurofins, Sengenics, Ambry, Macrogen, BGI, Novo Gene

What are the Application segmentation covered in the Whole Exome Sequencing Market report?

Ans: The Applications covered in the Whole Exome Sequencing Market report are Correlation Research of Normal Human, Mendelian Disease and Rare Syndrome Gene Discovery, The Research of Complex Diseases, Mouse Exome Sequencing

What are the Type segmentation covered in the Whole Exome Sequencing Market report?

Ans: The Types covered in the Whole Exome Sequencing Market report are Agilent HaloPlex, Agilent SureSelect, Agilent SureSelect QXT, Illumina TruSeq Exome, Roche Nimblegen SeqCap, MYcroarray MYbaits

Recommended Reports

Sequencing Technology

Genomic Data Analysis

Genetic Testing Markets

1 Study Coverage
1.1 Whole Exome Sequencing Product Introduction
1.2 Market by Type
1.2.1 Global Whole Exome Sequencing Market Size Growth Rate by Type (2020 VS 2024 VS 2031)
1.2.2 Agilent HaloPlex
1.2.3 Agilent SureSelect
1.2.4 Agilent SureSelect QXT
1.2.5 Illumina TruSeq Exome
1.2.6 Roche Nimblegen SeqCap
1.2.7 MYcroarray MYbaits
1.3 Market by Application
1.3.1 Global Whole Exome Sequencing Market Size Growth Rate by Application (2020 VS 2024 VS 2031)
1.3.2 Correlation Research of Normal Human
1.3.3 Mendelian Disease and Rare Syndrome Gene Discovery
1.3.4 The Research of Complex Diseases
1.3.5 Mouse Exome Sequencing
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Whole Exome Sequencing Market Size Estimates and Forecasts
2.2 Whole Exome Sequencing Market Size by Region: 2024 Versus 2031
2.2.1 Global Whole Exome Sequencing Revenue by Region: 2020-2025
2.2.2 Global Whole Exome Sequencing Revenue Forecast by Region (2026-2031)
2.2.3 Global Whole Exome Sequencing Revenue Market Share by Region (2020-2031)
3 Market Segments
3.1 Breakdown Data by Type
3.1.1 Global Whole Exome Sequencing Revenue by Type (2020-2031)
3.1.2 Global Whole Exome Sequencing Revenue Market Share by Type (2020-2031)
3.2 Breakdown Data by Application
3.2.1 Global Whole Exome Sequencing Revenue by Application (2020-2031)
3.2.2 Global Whole Exome Sequencing Revenue Market Share by Application (2020-2031)
3.3 by Type and by Application Crossing Analysis
3.3.1 Agilent HaloPlex of Whole Exome Sequencing Revenue Market Share by Application
3.3.2 Agilent SureSelect of Whole Exome Sequencing Revenue Market Share by Application
3.3.3 Agilent SureSelect QXT of Whole Exome Sequencing Revenue Market Share by Application
3.3.4 Illumina TruSeq Exome of Whole Exome Sequencing Revenue Market Share by Application
3.3.5 Roche Nimblegen SeqCap of Whole Exome Sequencing Revenue Market Share by Application
3.3.6 MYcroarray MYbaits of Whole Exome Sequencing Revenue Market Share by Application
4 Global Whole Exome Sequencing by Company
4.1 Global Whole Exome Sequencing Revenue by Company (2020-2025)
4.2 Global Whole Exome Sequencing Revenue Share by Company (2020-2025)
4.3 Competitive Landscape
4.3.1 Key Whole Exome Sequencing Companies around the World: Ranking by Revenue
4.3.2 Global Whole Exome Sequencing Market Concentration Ratio (CR5 and HHI) & (2020-2025)
4.3.3 Global Whole Exome Sequencing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.4 Global Whole Exome Sequencing Companies Headquarters & Product Type
4.4.1 Global Whole Exome Sequencing Companies Headquarters
4.4.2 Date of International Companies Enter into Whole Exome Sequencing Market
4.4.3 Global Whole Exome Sequencing Companies Product & Service
4.4.4 Agilent HaloPlex Revenue Market Share of Whole Exome Sequencing by Company
4.4.5 Agilent SureSelect Revenue Market Share of Whole Exome Sequencing by Company
4.4.6 Agilent SureSelect QXT Revenue Market Share of Whole Exome Sequencing by Company
4.4.7 Illumina TruSeq Exome Revenue Market Share of Whole Exome Sequencing by Company
4.4.8 Roche Nimblegen SeqCap Revenue Market Share of Whole Exome Sequencing by Company
4.4.9 MYcroarray MYbaits Revenue Market Share of Whole Exome Sequencing by Company
4.5 Global Whole Exome Sequencing Mergers & Acquisitions, Expansion Plans
5 Company Profiles
5.1 Illumina
5.1.1 Illumina Corporation Information
5.1.2 Illumina Description, Business Overview
5.1.3 Illumina Whole Exome Sequencing Products Offered
5.1.4 Illumina Whole Exome Sequencing Revenue and Gross Margin (2020-2025)
5.1.5 Illumina Whole Exome Sequencing Revenue by Product in 2024
5.1.6 Illumina Whole Exome Sequencing Revenue by Application in 2024
5.1.7 Illumina Whole Exome Sequencing Revenue by Geographic Area in 2024
5.1.8 Illumina Recent Developments
5.2 Thermo Fisher
5.2.1 Thermo Fisher Corporation Information
5.2.2 Thermo Fisher Description, Business Overview
5.2.3 Thermo Fisher Whole Exome Sequencing Products Offered
5.2.4 Thermo Fisher Whole Exome Sequencing Revenue and Gross Margin (2020-2025)
5.2.5 Thermo Fisher Whole Exome Sequencing Revenue by Product in 2024
5.2.6 Thermo Fisher Whole Exome Sequencing Revenue by Application in 2024
5.2.7 Thermo Fisher Whole Exome Sequencing Revenue by Geographic Area in 2024
5.2.8 Thermo Fisher Recent Developments
5.3 Roche
5.3.1 Roche Corporation Information
5.3.2 Roche Description, Business Overview
5.3.3 Roche Whole Exome Sequencing Products Offered
5.3.4 Roche Whole Exome Sequencing Revenue and Gross Margin (2020-2025)
5.3.5 Roche Whole Exome Sequencing Revenue by Product in 2024
5.3.6 Roche Whole Exome Sequencing Revenue by Application in 2024
5.3.7 Roche Whole Exome Sequencing Revenue by Geographic Area in 2024
5.3.8 Roche Recent Developments
5.4 Angilent
5.4.1 Angilent Corporation Information
5.4.2 Angilent Description, Business Overview
5.4.3 Angilent Whole Exome Sequencing Products Offered
5.4.4 Angilent Whole Exome Sequencing Revenue and Gross Margin (2020-2025)
5.4.5 Angilent Whole Exome Sequencing Revenue by Product in 2024
5.4.6 Angilent Whole Exome Sequencing Revenue by Application in 2024
5.4.7 Angilent Whole Exome Sequencing Revenue by Geographic Area in 2024
5.4.8 Angilent Recent Developments
5.5 Eurofins
5.5.1 Eurofins Corporation Information
5.5.2 Eurofins Description, Business Overview
5.5.3 Eurofins Whole Exome Sequencing Products Offered
5.5.4 Eurofins Whole Exome Sequencing Revenue and Gross Margin (2020-2025)
5.5.5 Eurofins Whole Exome Sequencing Revenue by Product in 2024
5.5.6 Eurofins Whole Exome Sequencing Revenue by Application in 2024
5.5.7 Eurofins Whole Exome Sequencing Revenue by Geographic Area in 2024
5.5.8 Eurofins Recent Developments
5.6 Sengenics
5.6.1 Sengenics Corporation Information
5.6.2 Sengenics Description, Business Overview
5.6.3 Sengenics Whole Exome Sequencing Products Offered
5.6.4 Sengenics Whole Exome Sequencing Revenue and Gross Margin (2020-2025)
5.6.5 Sengenics Whole Exome Sequencing Revenue by Product in 2024
5.6.6 Sengenics Whole Exome Sequencing Revenue by Application in 2024
5.6.7 Sengenics Whole Exome Sequencing Revenue by Geographic Area in 2024
5.6.8 Sengenics Recent Developments
5.7 Ambry
5.7.1 Ambry Corporation Information
5.7.2 Ambry Description, Business Overview
5.7.3 Ambry Whole Exome Sequencing Products Offered
5.7.4 Ambry Whole Exome Sequencing Revenue and Gross Margin (2020-2025)
5.7.5 Ambry Whole Exome Sequencing Revenue by Product in 2024
5.7.6 Ambry Whole Exome Sequencing Revenue by Application in 2024
5.7.7 Ambry Whole Exome Sequencing Revenue by Geographic Area in 2024
5.7.8 Ambry Recent Developments
5.8 Macrogen
5.8.1 Macrogen Corporation Information
5.8.2 Macrogen Description, Business Overview
5.8.3 Macrogen Whole Exome Sequencing Products Offered
5.8.4 Macrogen Whole Exome Sequencing Revenue and Gross Margin (2020-2025)
5.8.5 Macrogen Whole Exome Sequencing Revenue by Product in 2024
5.8.6 Macrogen Whole Exome Sequencing Revenue by Application in 2024
5.8.7 Macrogen Whole Exome Sequencing Revenue by Geographic Area in 2024
5.8.8 Macrogen Recent Developments
5.9 BGI
5.9.1 BGI Corporation Information
5.9.2 BGI Description, Business Overview
5.9.3 BGI Whole Exome Sequencing Products Offered
5.9.4 BGI Whole Exome Sequencing Revenue and Gross Margin (2020-2025)
5.9.5 BGI Whole Exome Sequencing Revenue by Product in 2024
5.9.6 BGI Whole Exome Sequencing Revenue by Application in 2024
5.9.7 BGI Whole Exome Sequencing Revenue by Geographic Area in 2024
5.9.8 BGI Recent Developments
5.10 Novo Gene
5.10.1 Novo Gene Corporation Information
5.10.2 Novo Gene Description, Business Overview
5.10.3 Novo Gene Whole Exome Sequencing Products Offered
5.10.4 Novo Gene Whole Exome Sequencing Revenue and Gross Margin (2020-2025)
5.10.5 Novo Gene Whole Exome Sequencing Revenue by Product in 2024
5.10.6 Novo Gene Whole Exome Sequencing Revenue by Application in 2024
5.10.7 Novo Gene Whole Exome Sequencing Revenue by Geographic Area in 2024
5.10.8 Novo Gene Recent Developments
6 North America
6.1 North America Whole Exome Sequencing Market Size YoY Growth 2020-2031
6.2 North America Whole Exome Sequencing Market Facts & Figures by Country (2020-2031)
6.3 North America Whole Exome Sequencing Revenue by Type (2020-2025)
6.4 North America Whole Exome Sequencing Revenue by Application (2020-2025)
7 Asia-Pacific
7.1 Asia-Pacific Whole Exome Sequencing Market Size YoY Growth 2020-2031
7.2 Asia-Pacific Whole Exome Sequencing Market Facts & Figures by Region (2020-2031)
7.3 Asia-Pacific Whole Exome Sequencing Revenue by Type (2020-2025)
7.4 Asia-Pacific Whole Exome Sequencing Revenue by Application (2020-2025)
8 Europe
8.1 Europe Whole Exome Sequencing Market Size YoY Growth 2020-2031
8.2 Europe Whole Exome Sequencing Market Facts & Figures by Country (2020-2031)
8.3 Europe Whole Exome Sequencing Revenue by Type (2020-2025)
8.4 Europe Whole Exome Sequencing Revenue by Application (2020-2025)
9 Latin America
9.1 Latin America Whole Exome Sequencing Market Size YoY Growth 2020-2031
9.2 Latin America Whole Exome Sequencing Market Facts & Figures by Country (2020-2031)
9.3 Latin America Whole Exome Sequencing Revenue by Type (2020-2025)
9.4 Latin America Whole Exome Sequencing Revenue by Application (2020-2025)
10 Middle East and Africa
10.1 Latin America Whole Exome Sequencing Market Size YoY Growth 2020-2031
10.2 Middle East and Africa Whole Exome Sequencing Market Facts & Figures by Country (2020-2031)
10.3 Middle East and Africa Whole Exome Sequencing Revenue by Type (2020-2025)
10.4 Middle East and Africa Whole Exome Sequencing Revenue by Application (2020-2025)
11 Supply Chain and Sales Channel analysis
11.1 Whole Exome Sequencing Supply Chain Analysis
11.2 Whole Exome Sequencing Key Raw Materials and Upstream Suppliers
11.3 Whole Exome Sequencing Clients Analysis
11.4 Whole Exome Sequencing Sales Channel and Sales Model Analysis
11.4.1 Whole Exome Sequencing Distribution Channel Analysis: Indirect Sales VS Direct Sales
11.4.2 Whole Exome Sequencing Distribution Channel Analysis: Online Sales VS Offline Sales
11.4.3 Whole Exome Sequencing Distributors
12 Whole Exome Sequencing Market Dynamics
12.1 Whole Exome Sequencing Industry Trends
12.2 Whole Exome Sequencing Market Drivers
12.3 Whole Exome Sequencing Market Challenges
12.4 Whole Exome Sequencing Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
List of Tables
 Table 1. Global Whole Exome Sequencing Market Size Growth Rate (CAGR) by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Global Whole Exome Sequencing Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 3. Global Whole Exome Sequencing Market Size by Region (US$ Million): 2024 VS 2031
 Table 4. Global Whole Exome Sequencing Revenue by Region (2020-2025) & (US$ Million)
 Table 5. Global Whole Exome Sequencing Revenue Forecast by Region (2026-2031) & (US$ Million)
 Table 6. Global Whole Exome Sequencing Revenue by Type (2020-2025) & (US$ Million)
 Table 7. Global Whole Exome Sequencing Revenue Forecast by Type (2026-2031) & (US$ Million)
 Table 8. Global Whole Exome Sequencing Revenue by Application (2020-2025) & (US$ Million)
 Table 9. Global Whole Exome Sequencing Revenue Forecast by Application (2026-2031) & (US$ Million)
 Table 10. Whole Exome Sequencing Revenue by Company (2020-2025) & (US$ Million)
 Table 11. Whole Exome Sequencing Revenue Share by Company (2020-2025)
 Table 12. Ranking of Global Top Whole Exome Sequencing Players by Revenue (US$ Million) in 2024
 Table 13. Global Whole Exome Sequencing Companies Market Concentration Ratio (CR5 and HHI) & (2020-2025)
 Table 14. Global Whole Exome Sequencing by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Whole Exome Sequencing as of 2024)
 Table 15. Global Whole Exome Sequencing Companies Headquarters
 Table 16. Date of International Companies Enter into Whole Exome Sequencing Market
 Table 17. Global Whole Exome Sequencing Companies Product & Service
 Table 18. Global Whole Exome Sequencing Mergers & Acquisitions, Expansion Plans
 Table 19. Illumina Corporation Information
 Table 20. Illumina Description and Business Overview
 Table 21. Illumina Whole Exome Sequencing Product
 Table 22. Illumina Whole Exome Sequencing Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 23. Illumina Revenue Proportion of Whole Exome Sequencing by Product in 2024
 Table 24. Illumina Revenue Proportion of Whole Exome Sequencing by Application in 2024
 Table 25. Illumina Revenue Proportion of Whole Exome Sequencing by Geographic Area in 2024
 Table 26. Illumina Recent Developments
 Table 27. Thermo Fisher Corporation Information
 Table 28. Thermo Fisher Description and Business Overview
 Table 29. Thermo Fisher Whole Exome Sequencing Product
 Table 30. Thermo Fisher Whole Exome Sequencing Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 31. Thermo Fisher Revenue Proportion of Whole Exome Sequencing by Product in 2024
 Table 32. Thermo Fisher Revenue Proportion of Whole Exome Sequencing by Application in 2024
 Table 33. Thermo Fisher Revenue Proportion of Whole Exome Sequencing by Geographic Area in 2024
 Table 34. Thermo Fisher Recent Developments
 Table 35. Roche Corporation Information
 Table 36. Roche Description and Business Overview
 Table 37. Roche Whole Exome Sequencing Product
 Table 38. Roche Whole Exome Sequencing Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 39. Roche Revenue Proportion of Whole Exome Sequencing by Product in 2024
 Table 40. Roche Revenue Proportion of Whole Exome Sequencing by Application in 2024
 Table 41. Roche Revenue Proportion of Whole Exome Sequencing by Geographic Area in 2024
 Table 42. Roche Recent Developments
 Table 43. Angilent Corporation Information
 Table 44. Angilent Description and Business Overview
 Table 45. Angilent Whole Exome Sequencing Product
 Table 46. Angilent Whole Exome Sequencing Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 47. Angilent Revenue Proportion of Whole Exome Sequencing by Product in 2024
 Table 48. Angilent Revenue Proportion of Whole Exome Sequencing by Application in 2024
 Table 49. Angilent Revenue Proportion of Whole Exome Sequencing by Geographic Area in 2024
 Table 50. Angilent Recent Developments
 Table 51. Eurofins Corporation Information
 Table 52. Eurofins Description and Business Overview
 Table 53. Eurofins Whole Exome Sequencing Product
 Table 54. Eurofins Whole Exome Sequencing Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 55. Eurofins Revenue Proportion of Whole Exome Sequencing by Product in 2024
 Table 56. Eurofins Revenue Proportion of Whole Exome Sequencing by Application in 2024
 Table 57. Eurofins Revenue Proportion of Whole Exome Sequencing by Geographic Area in 2024
 Table 58. Eurofins Recent Developments
 Table 59. Sengenics Corporation Information
 Table 60. Sengenics Description and Business Overview
 Table 61. Sengenics Whole Exome Sequencing Product
 Table 62. Sengenics Whole Exome Sequencing Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 63. Sengenics Revenue Proportion of Whole Exome Sequencing by Product in 2024
 Table 64. Sengenics Revenue Proportion of Whole Exome Sequencing by Application in 2024
 Table 65. Sengenics Revenue Proportion of Whole Exome Sequencing by Geographic Area in 2024
 Table 66. Sengenics Recent Developments
 Table 67. Ambry Corporation Information
 Table 68. Ambry Description and Business Overview
 Table 69. Ambry Whole Exome Sequencing Product
 Table 70. Ambry Whole Exome Sequencing Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 71. Ambry Revenue Proportion of Whole Exome Sequencing by Product in 2024
 Table 72. Ambry Revenue Proportion of Whole Exome Sequencing by Application in 2024
 Table 73. Ambry Revenue Proportion of Whole Exome Sequencing by Geographic Area in 2024
 Table 74. Ambry Recent Developments
 Table 75. Macrogen Corporation Information
 Table 76. Macrogen Description and Business Overview
 Table 77. Macrogen Whole Exome Sequencing Product
 Table 78. Macrogen Whole Exome Sequencing Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 79. Macrogen Revenue Proportion of Whole Exome Sequencing by Product in 2024
 Table 80. Macrogen Revenue Proportion of Whole Exome Sequencing by Application in 2024
 Table 81. Macrogen Revenue Proportion of Whole Exome Sequencing by Geographic Area in 2024
 Table 82. Macrogen Recent Developments
 Table 83. BGI Corporation Information
 Table 84. BGI Description and Business Overview
 Table 85. BGI Whole Exome Sequencing Product
 Table 86. BGI Whole Exome Sequencing Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 87. BGI Revenue Proportion of Whole Exome Sequencing by Product in 2024
 Table 88. BGI Revenue Proportion of Whole Exome Sequencing by Application in 2024
 Table 89. BGI Revenue Proportion of Whole Exome Sequencing by Geographic Area in 2024
 Table 90. BGI Recent Developments
 Table 91. Novo Gene Corporation Information
 Table 92. Novo Gene Description and Business Overview
 Table 93. Novo Gene Whole Exome Sequencing Product
 Table 94. Novo Gene Whole Exome Sequencing Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 95. Novo Gene Revenue Proportion of Whole Exome Sequencing by Product in 2024
 Table 96. Novo Gene Revenue Proportion of Whole Exome Sequencing by Application in 2024
 Table 97. Novo Gene Revenue Proportion of Whole Exome Sequencing by Geographic Area in 2024
 Table 98. Novo Gene Recent Developments
 Table 99. North America Whole Exome Sequencing Revenue by Country (2020-2025) & (US$ Million)
 Table 100. North America Whole Exome Sequencing Revenue by Country (2026-2031) & (US$ Million)
 Table 101. North America Whole Exome Sequencing Revenue by Type (2020-2025) & (US$ Million)
 Table 102. North America Whole Exome Sequencing Revenue by Application (2020-2025) & (US$ Million)
 Table 103. Asia-Pacific Whole Exome Sequencing Revenue by Region (2020-2025) & (US$ Million)
 Table 104. Asia-Pacific Whole Exome Sequencing Revenue by Region (2026-2031) & (US$ Million)
 Table 105. Asia-Pacific Whole Exome Sequencing Revenue by Type (2020-2025) & (US$ Million)
 Table 106. Asia-Pacific Whole Exome Sequencing Revenue by Application (2020-2025) & (US$ Million)
 Table 107. Europe Whole Exome Sequencing Revenue by Country (2020-2025) & (US$ Million)
 Table 108. Europe Whole Exome Sequencing Revenue by Country (2026-2031) & (US$ Million)
 Table 109. Europe Whole Exome Sequencing Revenue by Type (2020-2025) & (US$ Million)
 Table 110. Europe Whole Exome Sequencing Revenue by Application (2020-2025) & (US$ Million)
 Table 111. Latin America Whole Exome Sequencing Revenue by Country (2020-2025) & (US$ Million)
 Table 112. Latin America Whole Exome Sequencing Revenue by Country (2026-2031) & (US$ Million)
 Table 113. Latin America Whole Exome Sequencing Revenue by Type (2020-2025) & (US$ Million)
 Table 114. Latin America Whole Exome Sequencing Revenue by Application (2020-2025) & (US$ Million)
 Table 115. Middle East and Africa Whole Exome Sequencing Revenue by Country (2020-2025) & (US$ Million)
 Table 116. Middle East and Africa Whole Exome Sequencing Revenue by Country (2026-2031) & (US$ Million)
 Table 117. Middle East and Africa Whole Exome Sequencing Revenue by Type (2020-2025) & (US$ Million)
 Table 118. Middle East and Africa Whole Exome Sequencing Revenue by Application (2020-2025) & (US$ Million)
 Table 119. Whole Exome Sequencing Key Raw Materials, Industry Status and Trend
 Table 120. Whole Exome Sequencing Key Raw Materials and Upstream Suppliers
 Table 121. Whole Exome Sequencing Clients Status and Trend
 Table 122. Whole Exome Sequencing Typical Clients
 Table 123. Whole Exome Sequencing Distributors
 Table 124. Whole Exome Sequencing Market Trends
 Table 125. Whole Exome Sequencing Market Drivers
 Table 126. Whole Exome Sequencing Market Challenges
 Table 127. Whole Exome Sequencing Market Restraints
 Table 128. Research Programs/Design for This Report
 Table 129. Key Data Information from Secondary Sources
 Table 130. Key Data Information from Primary Sources


List of Figures
 Figure 1. Whole Exome Sequencing Product Picture
 Figure 2. Global Whole Exome Sequencing Market Size by Type (US$ Million): 2020 VS 2024 VS 2031
 Figure 3. Global Whole Exome Sequencing Revenue Market Share by Type in 2024 & 2031
 Figure 4. Agilent HaloPlex Product Picture
 Figure 5. Agilent SureSelect Product Picture
 Figure 6. Agilent SureSelect QXT Product Picture
 Figure 7. Illumina TruSeq Exome Product Picture
 Figure 8. Roche Nimblegen SeqCap Product Picture
 Figure 9. MYcroarray MYbaits Product Picture
 Figure 10. Global Whole Exome Sequencing Market Size by Application (US$ Million): 2020 VS 2024 VS 2031
 Figure 11. Global Whole Exome Sequencing Revenue Market Share by Application in 2024 & 2031
 Figure 12. Correlation Research of Normal Human
 Figure 13. Mendelian Disease and Rare Syndrome Gene Discovery
 Figure 14. The Research of Complex Diseases
 Figure 15. Mouse Exome Sequencing
 Figure 16. Whole Exome Sequencing Report Years Considered
 Figure 17. Global Whole Exome Sequencing Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 18. Global Whole Exome Sequencing Market Size (2020-2031) & (US$ Million)
 Figure 19. Global Whole Exome Sequencing Market Size Market Share by Region: 2024 Versus 2031
 Figure 20. Global Whole Exome Sequencing Revenue Market Share by Region (2020-2031)
 Figure 21. Global Whole Exome Sequencing Revenue Market Share Forecast by Type (2020-2031)
 Figure 22. Global Whole Exome Sequencing Revenue Market Share Forecast by Application (2020-2031)
 Figure 23. Agilent HaloPlex of Whole Exome Sequencing Revenue Market Share by Application, 2024 VS 2031
 Figure 24. Agilent SureSelect of Whole Exome Sequencing Revenue Market Share by Application, 2024 VS 2031
 Figure 25. Agilent SureSelect QXT of Whole Exome Sequencing Revenue Market Share by Application, 2024 VS 2031
 Figure 26. Illumina TruSeq Exome of Whole Exome Sequencing Revenue Market Share by Application, 2024 VS 2031
 Figure 27. Roche Nimblegen SeqCap of Whole Exome Sequencing Revenue Market Share by Application, 2024 VS 2031
 Figure 28. MYcroarray MYbaits of Whole Exome Sequencing Revenue Market Share by Application, 2024 VS 2031
 Figure 29. Whole Exome Sequencing Revenue Share by Company (2024)
 Figure 30. Whole Exome Sequencing Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 31. Agilent HaloPlex Revenue Proportion by Company in 2024
 Figure 32. Agilent SureSelect Revenue Proportion by Company in 2024
 Figure 33. Agilent SureSelect QXT Revenue Proportion by Company in 2024
 Figure 34. Illumina TruSeq Exome Revenue Proportion by Company in 2024
 Figure 35. Roche Nimblegen SeqCap Revenue Proportion by Company in 2024
 Figure 36. MYcroarray MYbaits Revenue Proportion by Company in 2024
 Figure 37. North America Whole Exome Sequencing Revenue 2020-2031 (US$ Million)
 Figure 38. North America Whole Exome Sequencing Revenue Market Share by Type (2020-2025)
 Figure 39. North America Whole Exome Sequencing Revenue Market Share by Application (2020-2025)
 Figure 40. Asia-Pacific Whole Exome Sequencing Revenue 2020-2031 (US$ Million)
 Figure 41. Asia-Pacific Whole Exome Sequencing Revenue Market Share by Region (2020-2031)
 Figure 42. Asia-Pacific Whole Exome Sequencing Revenue Market Share by Type (2020-2025)
 Figure 43. Asia-Pacific Whole Exome Sequencing Revenue Market Share by Application (2020-2025)
 Figure 44. Europe Whole Exome Sequencing Revenue Growth Rate 2020-2031 (US$ Million)
 Figure 45. Europe Whole Exome Sequencing Revenue Market Share by Country (2020-2031)
 Figure 46. Europe Whole Exome Sequencing Revenue Market Share by Type (2020-2025)
 Figure 47. Europe Whole Exome Sequencing Revenue Market Share by Application (2020-2025)
 Figure 48. Latin America Whole Exome Sequencing Revenue Growth Rate 2020-2031 (US$ Million)
 Figure 49. Latin America Whole Exome Sequencing Revenue Market Share by Country (2020-2031)
 Figure 50. Latin America Whole Exome Sequencing Revenue Market Share by Type (2020-2025)
 Figure 51. Latin America Whole Exome Sequencing Revenue Market Share by Application (2020-2025)
 Figure 52. Middle East and Africa Whole Exome Sequencing Revenue Growth Rate 2020-2031 (US$ Million)
 Figure 53. Middle East and Africa Whole Exome Sequencing Revenue Market Share by Country (2020-2031)
 Figure 54. Middle East and Africa Whole Exome Sequencing Revenue Market Share by Type (2020-2025)
 Figure 55. Middle East and Africa Whole Exome Sequencing Revenue Market Share by Application (2020-2025)
 Figure 56. Whole Exome Sequencing Supply Chain (Upstream and Downstream Market)
 Figure 57. Global Production Market Share of Whole Exome Sequencing Raw Materials by Region in 2024
 Figure 58. Whole Exome Sequencing Distribution Channels
 Figure 59. Global Whole Exome Sequencing Percentage 2020-2031: Indirect Sales VS Direct Sales
 Figure 60. Global Whole Exome Sequencing Percentage 2020-2031: Online Sales VS Offline Sales
 Figure 61. Bottom-up and Top-down Approaches for This Report
 Figure 62. Data Triangulation
 Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$5900

This license allows only one user to access the PDF.
Electronic (PDF)

$8850

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$11800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

SIS Group of Schools